US Patent Issued to BEIJING TIDE PHARMACEUTICAL on April 7 for "Pyrazolopyrimidine compound used as ATR kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,263, issued on April 7, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing).

"Pyrazolopyrimidine compound used as ATR kinase inhibitor" was invented by Cheung Ling Cheng (Beijing), Yanping Zhao (Beijing), Hongjun Wang (Beijing), Bin Liu (Beijing), Weiting Zhong (Beijing), Huifen Xu (Beijing), Chuangchuang Huang (Beijing), Jing Li (Beijing) and Weina Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a compound of a general formula (I), which may be used for the treatment of ATR kinase-mediated diseases, for example, proliferative diseases such as cancer. Further disclosed are a preparation method for the compound of ...